View email in your browser

Special Savings Offer

With the Bausch + Lomb Access Program,
most eligible commercially insured patients pay no more than*


(1st Rx and refills).

Discounted pricing is also available for eligible uninsured patients*

*Terms and conditions apply. Please see for eligibility criteria and terms and conditions.

Please see Indication and Important Safety Information below

Lotemax Gel


LOTEMAX® GEL (loteprednol etabonate ophthalmic gel) 0.5% is indicated for the treatment of post-operative inflammation and pain following ocular surgery.

Important Safety Information about LOTEMAX® GEL

LOTEMAX® GEL is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures.
Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision. If this product is used for 10 days or longer, IOP should be monitored.
Use of corticosteroids may result in posterior subcapsular cataract formation.
Use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation and occurrence of perforations in those with diseases causing corneal and scleral thinning. The initial prescription and renewal of the medication order should be made by a physician only after examination of the patient with the aid of magnification, and where appropriate, fluorescein staining.
Prolonged use of corticosteroids may suppress the host response and thus increase the hazard of secondary ocular infection. In acute purulent conditions, steroids may mask infection or enhance existing infection.
Use of a corticosteroid medication in the treatment of patients with a history of herpes simplex requires great caution. Use of ocular steroids may prolong the course and exacerbate the severity of many viral infections of the eye (including herpes simplex).
Fungal infections of the cornea are particularly prone to develop coincidentally with long-term local steroid application. Fungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use.
Patients should not wear contact lenses when using LOTEMAX® GEL.
The most common ocular adverse drug reactions were anterior chamber inflammation (5%), eye pain (2%) and foreign body sensation (2%).

Please click here for full Prescribing Information for LOTEMAX® GEL.


®/TM are trademarks of Bausch & Lomb Incorporated or its affiliates.
Any other product/brand names are trademarks of the respective owners.
©Bausch & Lomb Incorporated. All rights reserved. LGX.0036.USA.17

Bryn Mawr Communications | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to General Ophthalmology Partner Emails from Bryn Mawr Communications.
Manage Preferences | Unsubscribe | Contact Us